Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
Background. Inflammation-driven immune dysfunction supports the development of several chronic human disorders including skin diseases. Nonantibiotic macrolides have anti-inflammatory and/or immunomodulatory activity that suggests the exploitation of these in the treatment of skin diseases character...
Saved in:
Main Authors: | Carmen Rodriguez-Cerdeira, Elena Sanchez-Blanco, Alberto Molares-Vila |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/563709 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrolides in Chronic Inflammatory Skin Disorders
by: Abdullateef A. Alzolibani, et al.
Published: (2012-01-01) -
Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01) -
Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999-01-01) -
Editorial: Key players of the immune system in skin inflammation—allergy and autoimmunity
by: Laila Karra Khalil, et al.
Published: (2025-01-01) -
Effects of macrolide antibiotics on blood inflammatory mediators and organ damage markers in lipopolysaccharide-induced pulmonary damage rats
by: Ayşe Er, et al.